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BACKGROUND: Infants and children living with HIV receive antiretroviral treatment often late, are 
exposed to opportunistic infection and quickly develop AIDS. Few hospitals are providing ART service 
after Dried Blood Spot (DBS)test.The objective of this study is to assess the status of infants and children 
linked to ART. 
METHODS: Descriptive cross-sectional study was conducted in hospitals. Data of 138 infants and 
children exposed to HIV were collected  from registration books and data bases from 2009 to 2011. Data 
were analyzed using SPSS version 16. Chi-squared test and p-value were computed. In-depth interviews 
were conducted with  key informants. 
RESULT: Ninety-eight (71%) infants and children exposed to HIV were diagnosed for HIV infection of 
which 68(69.4%) initiated ART. Twenty four (35.3%) initiated ART one month after HIV screening 
results. Thirty-three (50.0%) and 23(35.3%) infants and children dropped from and adhered to ART 
respectively. Eleven (16.2%) of them who initiated ART died within the study period.  HIV infection 
status (p-value=0.003), dropping from ART (p-value=0.002) and death after ART initiation (p-
value=0.010) showed significance with mothers’ PMTCT service status. 
CONCLUSION: Seven in ten HIV-exposed infants and children were diagnosed with HIV, and almost 
all of them initiated ART. The overall turnaround time was 10 days. Based up on mothers’ PMTCT 
service status, there was a significant difference among HIV-exposed infants and children in acquiring 
HIV infection from mothers during pregnancy (p-value=0.003) and dropping from ART (p-value=0.010). 
There were challenges in sample collection and transportation. Early HIV screening during pregnancy 
and PMTCT service should be strengthened.  
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INTRODUCTION   
 
Children bear a heavy burden of HIV infection 
(1,2).  In 2009 alone, 370,000 infants and children 
were newly infected of which 260,000 died. 
Children make up approximately of 7 percent of 
the total number of people living with HIV 
worldwide. In the same year, fewer than 200,000 
children living with HIV received antiretroviral 
treatment. Further, those on Highly Active Anti-
Retroviral Treatment (HAART) often receive it 
too late for the median age of five and nine years 
old (2). 
Globally in 2009, there were 33.3 million adults 
and children estimated to live with HIV/AIDS. 
Two and half million were infants and children 
living with HIV/AIDS of which approximately 
90% were in sub-Saharan Africa.  When infants 
and children with HIV are failed to take HAART, 
half of them will be die by the age of two years 
and three fourth will die within five years (1). HIV 
testing from DBS using DNA PCR testing makes 
a definitive diagnosis in children below 18 
months. This solves confusion of HIV test with 
persistence of maternal antibodies until 
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this age (3). In Ethiopia, by January 2009, Early 
Infant Diagnosis (EID) began in 58 hospitals and 
23 health centers. In the same year, the number of 
infants and children tested almost doubled from 
692 to 1340. Infants and children referred from 
PMTCT (Prevention of Mother to Child 
Transmission) and ART clinics, over the age of 
six weeks and below 12 months, and at some sites, 
below 18 months were tested (2). Despite these 
efforts , there still are challenges such as limited 
access to EID, limited trained staff, very few 
sample collection facilities, inadequate 
transportation and poor sample storage system, 
limited number of laboratories capable of 
performing DNA PCR and few linkages for HIV-




Study design and study participants: A 
descriptive hospital based cross-sectional study 
was conducted in 2013 from March to May in two 
referral hospitals (Jimma University Teaching 
Hospital and St. Luke Referral Hospital) by giving 
pediatric Anti-Retroviral Treatments in Ethiopia. 
The study population included all registered HIV- 
exposed infants and children from records of 2009 
to 2011. 
Sample size and sampling procedure: In the two 
hospitals, between 2009 and 2011, there were 150 
registered HIV-exposed infants and children 
whose HIV statuses were identified through DNA 
PCR by the regional laboratory. Then, study 
participants were identified at institution level 
based on set inclusion and exclusion criteria. The 
inclusion criteria were HIV-exposed infants and 
children < 18 months old, who were registered and 
screened within 2009 to 2011 in two hospitals. 
Twelve (12) HIV- exposed infants and children 
with no records on HIV status, treatment and 
mortality status and turnaround time status from 
registration book and computer data bases were 
excluded. As a result, data of only 138 (61 from 
St. Luke Referral Hospital and 77 from Jimma 
University Teaching Hospital) exposed infants and 
children who fulfilled the inclusion criteria were 
included. These two hospitals were purposively 
selected based on road accessibility, long and 
continuous followup of pediatric ART treatment 
status and availability of long Early Infant 
Diagnosis (EID) services. 
 
 
Data collection procedure: Data were collected 
by trained data collectors from registration books 
and computer data bases using checklist 
containing items on socio-demographic 
characteristics of parents/caregivers, HIV status, 
treatment status (ART initiation, dropout and 
adherence status), mortality status and turnaround 
time.  Five in-depth interviews were conducted 
using unstructured interview guide with with 
purposively selected key informants from two 
hospitals (physician and nurse) and a laboratory 
technologist working at a regional laboratory. 
Data processing and analysis: The data were 
edited and entered in to Epi-data version 3.1 for 
double entry verification and then transported to 
SPSS version 16.0 for windows for analysis. The 
findings were presented using frequency tables 
and p-values of chi-square tests. Mean and 
standard deviation were used to present findings 
of continuous variables. Thematic analysis was 
done for qualitative data and qualitative findings 
were triangulated with quantitative findings. P-
values less than 0.05 were taken as statistical 
association between variables.  
Operational definitions: 
 
The following operational definitions were used in 
this study.  
Treatment success: Initiation and continuation of 
HAART, improvement in CD4 count from the 
baseline, improvement in HIV WHO staging as 
per the WHO guideline for pediatric HIV 
treatment 
Treatment adherence: Treatment retention 
(appointment to visit health institution to take 
medication) and compliance with medication 
doses (missing not more than three of the 
prescribed doses for 1 month prior to the study)  
Dropouts: Lost to found after initiation of 
HAART from the two hospitals  
Turnaround time: The date from DBS sample 
collection of HIV-exposed infants and children 
from two hospitals to the date when HIV 
screening results from Regional Laboratory were 
received by two hospitals 
HIV exposure: Infants and children who were 
registered as “HIV-exposed infant and child” by 
two hospitals  
Apparently healthy mother: The HIV positive 
mother with no recognizable clinical symptoms of 
HIV. 
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Ethical clearance was secured from the 
Institutional Review Board (IRB) of Jimma 
University (JU), College of Health Sciences to 
conduct the study in the specified area. Letter of 
permission was obtained  from JU to communicate 
with and get permission from hospital managers. 
The respondents’ identities were kept confidential 
by avoiding identifiers. Written informed consent 
was obtained from hospital administrative bodies 
to get permission to take information from 
registration books. Consent was also obtained 




Socio-demographic characteristics of care 
givers of HIV-exposed infants and children: 
One hundred and thirty eight HIV-exposed infants 
and children in both hospitals were tested for  
against HIV infection by DNA/PCR. Data of 138 
HIV-exposed infants and children and their 
parents’ socio-demographic characteristics were 
collected. The results indicated that 136(98.6%) 
caregivers of the HIV-exposed infants and 
children were biological parents out of which 
130(94.2%) were females. One hundred and 
eleven (80.4%) caregivers were in the age range of 
17 to 35 years, 23(16.7%) were 36 to 49 years old 
while 4(2.9%) were ≥50 years old with the mean 
age of 30.2(SD=7.3) years (Table 1).    
The study also depicted that 103(74.6%) of 
the caregivers were married, 13(9.4%) were 
single, 9(6.5%) were divorced and 12(8.7%) were 
widowed. Sixty-nine (50.0%) caregivers were 
illiterate, 10(7.2%) could read and write, 
37(26.8%) while 17(12.3%) were at primary and 
secondary educational level respectively. Ninety- 
four (68.1%) of the caregivers had five and below 
family members while 44(31.9) of them had above 
five families members with average family size of 
4.55 (Table 1).   
The finding of the study also indicated that 
104(74.5%) mothers initiated ART, while they 
were pregnant with index child. PMTCT service 
was provided to 81(58.7%) mothers while they 
were pregnant with index child. One hundred and 
sixteen (84.1%) mothers were apparently healthy 
before and during data collection period (Table 1). 
Turnaround time of screening results of HIV- 
exposed infants and children: Out of 138 infants 
and children, HIV status of 123(89.1%) was 
identified and reported within two weeks of DBS 
sample collection. The qualitative findings from 
the Regional Laboratory also showed that 
DNA/PCR laboratory was equipped with data 
management system (data clerk and better 
network), sponsored and supervised by 
ICAP/Ethiopia.  
The overall turnaround was 10 days. One of 
the in-depth interviewees emphasized that care 
givers did not appear on the appointment time 
given during DBS sample collection for result 
notification. From 138 exposed infants and 
children, HIV status of 15(10.9%) was identified 
and reported after two weeks of DBS sample 
collection from. One of the interviewees explained 
that, sometimes, DBS samples from the respective 
hospitals to the post office were delayed due to 
absence of assigned persons. The hospitals had 
poor mechanism to assure whether post offices 
transported the samples to the Regional 
Laboratory immediately. The regional laboratory, 
sometimes, did not check their post offices for 
arrival of DBS samples. 
HIV status of HIV exposed infants and 
children: Data were collected on 138 HIV- 
exposed infants and children of which 67(48.6%) 
and 71(51.4%) were males and females. From 138 
HIV-exposed infants and children, 98(71%) of 
them were diagnosed for HIV infection by 
DNA/PCR. From infants and children diagnosed 
with HIV,48(49.0%) and 50(51.0%) were males 
and females respectively. Seventy-two (52.2%), 
59(42.8%) and 7(5.0%) HIV-exposed infants and 
children were below 6 months old, 7-12 months 
old and 13-18 months old respectively. The mean 
age of HIV-exposed infants and children was 7.6 
(SD=3.8) months. Thirty-seven (37.8%), 
54(55.1%) and 7(71.5%)  of the HIV positive 
infants and children were below 6, 7-12 and 13-18 













Table 1: Socio-demographic characteristics of caregivers of infants and children, 2009-2011. 
 
 




Caregiver Biological  136 98.6 
Non-biological  2 1.4 
Age in years 17-35 111 80.4 
36-49 23 16.7 
≥50 4 2.9 
Sex  Male  8 5.8 
Female  130 94.2 
Occupational status Farmer  48 34.8 
Merchant  28 20.3 
Employee 18 13.0 
House wife 38 27.5 
Day laborer 6 4.3 
Marital status  
 
Married  103 74.6 
Single  13 9.4 
Divorced  9 6.5 
Widowed  12 8.7 
Other  1 .7 
Educational status Illiterate  69 50.0 
Read and write  10 7.2 
Primary  37 26.8 
Secondary 17 12.3 
       Religion  Muslim  38 27.5 
Orthodox  63 45.7 
Catholic  3 2.2 
Protestant  34 24.6 
       Family size ≤5 94 68.1 
≥6 44 31.9 
      Was mother on ART Yes  104 75.4 
No 34 24.6 
       Was PMTCT given service  Yes  81 58.7 
No 28 20.3 
Unknown  29 21.0 
       Health status of mother  Apparently healthy  116 84.1 
Ill 11 8.0 
Died  3 2.2 




Fifty-three (64.1%) HIV-exposed infants and 
children born from 81(58.7%) mothers provided 
with PMTCT service were infected with HIV 
virus. Seventeen (60.7%) HIV-exposed infants 
and children born from 29(20.3%) mothers with 
no PMTCT service were infected with HIV virus, 
while 28(96.6%) HIV-exposed infants and 
children born from 29(21.3%) mothers with 
unknown PMTCT service status were infected 
with HIV virus.  The association between the 
PMTCT service and HIV infection status of 
infants and children indicated that there was a 
significant difference among HIV-exposed infants 
and children in acquiring HIV infection from their 
mothers depending on PMTCT service status of 
the mothers during pregnancy (p-value=0.003) 
(Table 3).   
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ART initiation, dropout/adherence and 
mortality status of HIV diagnosed infants and 
children:   The study indicated that of the infants 
and children diagnosed to have HIV infection, 
68(69.4%) initiated ART treatment (Table 2). 
After the reception of DNA/PCR results, 
26(38.2%) infants and children initiated ART 
within seven days, 18(26.5%) of them initiated 
ART within 8 to 30 days and 24(35.3%) of them 
initiated ART after 30 days following HIV 
infection status notification by the hospitals. One 
of the in-depth interviewees emphasized that care 
givers did not appear on the appointment time 
during DBS sample collection for result 
notification. The association between the PMTCT 
service and initiation of ART for infants and 
children diagnosed to have HIV infection 
indicated no significant difference in ART 
initiation for infants and children diagnosed HIV-
positive  based on PMTCT service status of their 
mothers during pregnancy (p value=0.405) (Table 
3).  
The study indicated that of the infants and 
children who initiated ART treatments, 34(50.0%) 
dropped from ART treatment (Table 2).  The 
association between the PMTCT service and 
dropping from ART treatment indicated a 
significant difference in dropping from ART 
among infants and children who initiated ART 
based on PMTCT service status of the mothers 
during pregnancy (p-value=0.002) (Table 3).  
The study also indicated that of the infants 
and children who initiated ART, 28(80%) adhered 
to ART. Eleven (16.18%) of the infants and 
children died after they had initiated ART. The 
association between the PMTCT service and death 
after ART was initiated indicated significant 
difference in death among infants and children 
who initiated ART based on PMTCT service 
status of their mothers during pregnancy (p-
value=0.010)  (Table 2).  
 
Table 2: Treatment and mortality status of HIV diagnosed with infants and children, 2009-2011. 
 
 
Variable   Number     Percent  
Age in months  
 
< 6  72 52.2 
7-12  59 42.8 
13-18 7 5.0 
Total  138 100 
  Sex  Male  67 48.6 
Female  71 51.4 
Total  138 100 
HIV status HIV+  98 71.0 
HIV- 40  29.0 
       Was child initiated ART Yes  68 69.4 
No 30 30.6 
Total  98 100 
Was child dropped ART Yes  34 50.0 
No  34 50.0 
Total  68 100 
Mortality status Yes  11 16.2 
No  23 33.8 
Unknown  34 50.0 
Total  68 100 
Was child adhered to ART Yes  27 79.4 
No  7 20.6 









Table 3: The relationship between PMTCT service and treatment and mortality status of HIV diagnosed 






            PMTCT service provided to mother   
 
P-value 
Yes                       No Unknown 
No  Percent  No  Percent  No Percent  
HIV status of infant and child HIV+  53 65.4 17 60.7 28 96.6 0.003 
HIV- 28 34.6 11 39.3 1 3.4 
Child initiated ART  Yes  34 64.2 12 70.2 22 78.6 0.405 
No 19 35.8 5 29.4 6 21.4 
Child dropped from ART Yes  17 50.0 11 91.7 5 27.3 0.002 
No 17 50.0 1 8.3 17 72.7 
Child Mortality status  Died 4 11.8 0 0.0 7 31.8 * 
Alive  13 38.2 1 8.3 9 40.9 
Uk** 17 50.0 11 91.7 6 27.3 
Child  adhered to ART  Yes  14 82.4 1 100.0 12 75.0 * 
No   3 17.6 0 0.0  4 25.0 




This study determined the HIV infection status, 
dropout, adherence rates and turnaround time 
among HIV-exposed infants and children. In 2010, 
in the region where this study was conducted, 
HIV-positive pregnant women were estimated to 
be 23,940. From these, annually 3,861 infants 
were expected to be born with the virus. Focusing 
on testing efforts only on those known HIV-
exposed infants and children may result in missed 
opportunities  of HIV screening for truly HIV-
exposed infants and children (4–7).  
This study indicated that 57(42.0%) of 
mothers of the infants and children did not take 
PMTCT. This might be due to  lack of awareness 
among mothers about their HIV status during 
pregnancy of the index child. This can imply great 
risk for fetus to acquire HIV infection for mothers 
who had no ANC followup and  did not know 
their HIV status. HIV-infected mothers who were 
aware of their own HIV status might not shared 
their HIV status to pediatric providers (5–8).   
Fifty-three (64.1%) HIV-exposed infants and 
children born from 81(58.7%) mothers provided 
with PMTCT service were infected with HIV 
virus. Seventeen (60.7%) HIV-exposed infants 
and children born from 29(20.3%) mothers with 
no PMTCT service were infected with HIV virus, 
while 28(96.6%) HIV-exposed infants and 
children born from 29(21.3%) mothers with 
unknown PMTCT service status were infected 
with HIV virus.  The association between the 
PMTCT service and HIV status of infant and child 
indicated that there was a significant difference 
among HIV-exposed infants and children in 
acquiring HIV infection from their mother 
depending on PMTCT service status of the 
mothers during pregnancy (p-value=0.003). 
Strategies to improve linkage between PMTCT 
and pediatric records like child health cards 
indicating maternal HIV status (9) and integrated 
maternal and child health programs (10,11) are 
important. If there are no such efforts, many 
infants and children whose mothers are unaware 
of their own HIV infections can be missed.  
The study indicated that of 98(71%) infants 
and children diagnosed HIV-positive by 
DNA/PCR, ART was initiated for 68 (69.4%) 
infants and children. This figure is far higher than 
the findings in Botswana (12), Tanzania (13) and 
Malawi (14), which indicated ART was initiated 
for 45%, 46% and 55% infants and children with 
HIV respectively. These differences could be 
explained by the difference in hospital enrolment 
rate of infants and children for ART initiation, the 
study settings and the study samples. The study 
indicated that there was a significant difference 
among HIV-exposed infants and children in 
acquiring HIV infection (p-value=0.003), 
dropping from ART (p-value=0.002) and death 
after ART was initiated (p-value=0.010) based on 
PMTCT service status of their mothers. However, 
there was no significant difference among HIV-
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exposed infants and children in ART initiation (p-
value=0.802) and adherence to ART (p-
value=0.405) based on PMTCT service status of 
their mothers. These two findings could be 
explained by lack of HIV testing during pregnancy 
or false negative HIV antibody tests during acute 
maternal infection (15) or delayed ANC followup 
during pregnancy of the index child during the 
study period. These findings are also consistent 
with the findings of similar studies 
(12,16,17,15,18,19).  
This study had some limitations. Several 
records were incomplete on required variables in 
data sources. The size of the study might not 
represent status of exposed and diagnosed infants 
and children of all Regional Laboratories in 
Ethiopia due to limited study sites which might 
lead to statistical uncertainty. Another limitation 
of the study was that infants’ and children’s 
adherence to treatment through both hospitals was 
determined using records completed by health 
providers based on the information provided by  
mothers of infants and children, and by searching 
the followup compliance of infants based on their 
appointment dates. The information gathered from 
mothers of infants and children might have 
affected the validity of the study. This might in 
turn overestimate or underestimate adherence to 
ART. If the caregivers of infants and children had 
been directly interviewed and if all clinical 
markers had been applied, information about 
treatment adherence would have been more 
accurate. This study might not also have captured 
the exposure status of all infants and children of 
all HIV-positive mothers during antenatal 
followup.  
Despite the limitations explained above, this 
study identified some valuable facts on ART 
treatment status, mortality and turnaround time 
which provide an opportunity for further planning 
and evidence-based decision-making.    
In conclusion, the overall turnaround was 10 
days. There was a significant difference among 
HIV-exposed infants and children in acquiring 
HIV infection from their mothers and dropping 
from ART depending on PMTCT service status of 
the mothers during pregnancy. There was 
institutional and regional challenges on sample 
collection, transportation and processing. 
Successful reduction of new HIV infection during 
pregnancy, earlier HIV screening during 
pregnancy and provision of PMTCT service 
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